Ogsiveo approved in EU for treatment of desmoid tumors
Written by
PharmaTimes
Published
0
comments
0
min
Merck’s therapy becomes first authorised option for aggressive soft tissue tumours Merck’s therapy becomes first authorised option for aggressive soft tissue tumours